Advertisement
Screener

Korro Bio, Inc. (KRRO) Graph

KRRO Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $0.00; Research and development $13.59M; Operating expenses $20.11M; Income tax $108.00K.
  • 2026-03-31: Revenue $0.00; Research and development $12.95M; Operating expenses $20.44M; Income tax $95.00K.
  • 2025-12-31: Revenue $1.29M*; Research and development $10.98M*; Operating expenses $51.69M*; Income tax $636.00K*.
  • 2025-09-30: Revenue $1.09M; Research and development $13.82M; Operating expenses $20.33M; Income tax $0.00.

Revenue flow

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

KRRO revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Revenue$0.00Operating expenses$20.11MOperating income-$20.11MOther income, net$1.30MResearch & development$13.59MPre-tax income-$18.81MIncome tax$108.00KNet income-$18.92M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueResearch and developmentOperating expensesIncome taxNet income
2026-06-30$0.00$13.59M$20.11M$108.00K-$18.92M
2026-03-31$0.00$12.95M$20.44M$95.00K-$19.63M
2025-12-31$1.29M*$10.98M*$51.69M*$636.00K*-$50.04M*
2025-09-30$1.09M$13.82M$20.33M$0.00-$18.06M
2025-06-30$1.46M$20.14M$28.66M$1.00K-$25.77M
2025-03-31$2.55M$19.74M$27.57M$0.00-$23.39M
2024-09-30$0.00$15.96M$23.29M-$9.00K-$21.00M
2024-06-30$0.00$17.14M$24.13M$30.00K-$21.83M
2024-03-31$0.00$13.57M$21.45M$17.00K-$19.56M
2023-09-30(m)$14.01M$19.15M$0.00-$18.49M
2023-06-30(m)$13.13M$18.41M$27.00K-$17.65M
2023-03-31(m)$14.69M$20.09M$0.00-$19.61M
2022-12-31$0.00*(m)(m)(m)(m)
2022-09-30$0.00$11.71M$20.27M-$23.00K-$19.55M
2022-06-30$0.00$13.27M$21.27M$2.00K-$21.29M
2022-03-31$0.00$13.78M$23.26M$12.00K-$23.39M
2021-09-30$0.00$15.66M$24.99M$3.00K-$25.16M
2021-06-30$9.42M$17.40M$26.90M$10.00K-$17.66M
2021-03-31$4.65M$15.11M$24.85M$0.00-$20.38M
2020-12-31$9.95M(m)(m)(m)-$10.23M
2020-09-30$11.25M$10.15M$16.66M$15.00K-$5.34M
2020-06-30$8.52M$8.76M$14.72M$7.00K-$6.03M
2020-03-31$7.26M$6.67M$12.92M$38.00K-$4.91M
2019-12-31$4.71M(m)(m)(m)-$5.49M
2019-09-30$24.24M$5.22M$25.49M(m)-$575.00K
2019-06-30(m)$3.92M$7.02M(m)-$6.85M
2019-03-31(m)$3.45M$5.92M(m)-$5.83M
2018-12-31(m)(m)(m)(m)-$5.45M
2018-09-30(m)$3.55M$5.06M(m)-$5.14M
2018-06-30(m)(m)(m)(m)-$4.44M
2018-03-31(m)(m)(m)(m)-$4.15M

Revenue and expense 6 month

Period endRevenueResearch and developmentOperating expensesIncome taxNet income
2026-06-30$0.00$26.54M$40.55M$203.00K-$38.54M
2025-06-30$4.01M$39.87M$56.23M$1.00K-$49.16M
2024-06-30$0.00$30.71M$45.58M$47.00K-$41.38M
2023-06-30(m)$27.82M$38.49M$27.00K-$37.25M
2022-06-30$0.00$27.05M$44.53M$14.00K-$44.67M
2021-06-30$14.07M$32.51M$51.75M$10.00K-$38.03M
2020-06-30$15.79M$15.43M$27.64M$45.00K-$10.94M
2019-06-30(m)$7.37M$12.94M(m)-$12.68M

Revenue and expense 9 month

Period endRevenueResearch and developmentOperating expensesIncome taxNet income
2025-09-30$5.10M$54.59M$76.56M$1.00K-$67.22M
2024-09-30$0.00$46.67M$68.87M$38.00K-$62.38M
2023-09-30(m)$41.83M$57.64M$27.00K-$55.75M
2022-09-30$0.00$38.77M$64.81M-$9.00K-$64.22M
2021-09-30$14.07M$48.17M$76.74M$13.00K-$63.19M
2020-09-30$27.03M$25.59M$44.31M$60.00K-$16.28M
2019-09-30$24.24M$12.59M$38.42M$0.00-$13.25M
2018-09-30(m)$8.96M$13.62M$0.00-$13.72M

Revenue and expense 12 month

Period endRevenueResearch and developmentOperating expensesIncome taxNet income
2025-12-31$6.39M$65.58M$128.25M$637.00K-$117.26M
2024-12-31$2.27M$63.64M$94.18M$141.00K-$83.58M
2023-12-31$0.00$57.25M$84.53M$27.00K-$81.17M
2022-12-31$0.00$42.20M$59.00M$10.00K-$58.03M
2021-12-31$14.07M$60.92M$98.10M$15.00K-$84.69M
2020-12-31$36.98M$37.41M$64.53M$35.00K-$26.51M
2019-12-31$28.95M$18.78M$49.62M$0.00-$18.75M
2018-12-31(m)$11.88M$18.94M(m)-$19.17M
2017-12-31(m)$11.97M$16.31M(m)-$20.24M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Atrium Therapeutics, Inc. (RNA)United States$0.140B
SPRUCE BIOSCIENCES, INC. (SPRB)United States$0.142B-2.89
Curanex Pharmaceuticals Inc (CURX)United States$0.138B
Corbus Pharmaceuticals Holdings, Inc. (CRBP)United States$0.144B-1.72
Annexon, Inc. (ANNX)United States$0.147B-4.22
TuHURA Biosciences, Inc./NV (HURA)United States$0.134B-4.88
Unicycive Therapeutics, Inc. (UNCY)United States$0.134B-3.70
NRX Pharmaceuticals, Inc. (NRXP)United States$0.131B-6.31
MEDICINOVA INC (MNOV)United States$0.130B-6.04
IMMUNIC, INC. (IMUX)United States$0.127B-1.88